Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/TOPICAL HAPTEN GEL

Authorized

STANDARD

TOPICAL HAPTEN GEL

dormer laboratories inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 53f14a045b904838
Company: dormer laboratories inc.
Type: Standard

Approval Details

Approval Id: 53f14a045b904838
Drug Approval Canada Name: TOPICAL HAPTEN GEL
Product Name: TOPICAL HAPTEN GEL
Status: Marketed
Status Date: 2017-09-13
Original Market Date: 2017-09-13
Din: 02466333
Drug Class: Human
Dosage Form: Gel
Route Of Administration: Topical
Schedule: Schedule D
Ahfs: 92:05.00*
Atc Original: V04CL TESTS FOR ALLERGIC DISEASES
Atc Name: v 04 cl
Aig Number: 0159290002
Company Name: dormer laboratories inc.
Company Address: 5, 91 Kelfield Street, Toronto, Ontario, Canada, M9W 5A3

Active Ingredients

HAPTENS

100 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

53f14a045b904838

Type

Standard

Back to Health Canada Approvals

TOPICAL HAPTEN GEL - Health Canada Drug Approval Details